ASTA Pharma Aktiengesellschaft
Records under this name other than patents ASTA Pharma Aktiengesellschaft holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to ASTA Pharma Aktiengesellschaft
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,017,909 | Salts of azelastine having improved solubility effective at treating psoriasis and providing a cytoprotective effect Formerly held Term ended Term ended Aug 20, 2018 · From the USPTO record | Term ended | Term ended Aug 20, 2018 | From the USPTO record |
| US 6,271,254 | Pharmaceutical compositions containing R-.alpha.-lipoic acid or S-.alpha.-lipoic acid as active ingredient Formerly held Lapsed on the fee record Ended Aug 7, 2013 · From the USPTO record | Lapsed on the fee record | Ended Aug 7, 2013 | From the USPTO record |
| US 6,300,370 | Camomile oils having a high content of natural poly-ynes and process for their preparation Formerly held Lapsed on the fee record Ended Oct 9, 2009 · From the USPTO record | Lapsed on the fee record | Ended Oct 9, 2009 | From the USPTO record |
| US 4,618,692 | 4-Carbamoyloxy-oxazaphosphorins Term ended Term ended no later than Oct 21, 2006 · Low confidence | Term ended | Term ended no later than Oct 21, 2006 | Low confidence |
| US 4,623,742 | Oxazaphosphorin-4-thio-alkanesulphonic acids, and neutral salts thereof Term ended Term ended no later than Nov 18, 2006 · Low confidence | Term ended | Term ended no later than Nov 18, 2006 | Low confidence |
| US 4,659,699 | Process for freeze drying cyclophosphamide Term ended Term ended no later than Apr 21, 2007 · Low confidence | Term ended | Term ended no later than Apr 21, 2007 | Low confidence |
| US 4,770,870 | Method for reducing pain associated with the administration of 4-sulfido-oxazaphosphorines and 4-sulfoalkylthio-oxazaphorphorines Term ended Term ended no later than Sep 13, 2008 · Low confidence | Term ended | Term ended no later than Sep 13, 2008 | Low confidence |
| US 4,839,370 | Novel derivatives of 3-aryl-3-cycloalkyl-piperidine-2,6-dione Formerly held Term ended Term ended no later than Jun 13, 2009 · Low confidence | Term ended | Term ended no later than Jun 13, 2009 | Low confidence |
| US 4,841,047 | 4-benzyl-1-(2H)-phthalazinone-derivates Term ended Term ended no later than Jun 20, 2009 · Low confidence | Term ended | Term ended no later than Jun 20, 2009 | Low confidence |
| US 4,843,069 | Medicament formulations containing ruthenium compounds with an antitumoral action Formerly held Term ended Term ended no later than Jun 27, 2009 · Low confidence | Term ended | Term ended no later than Jun 27, 2009 | Low confidence |